n,n-dimethylarginine has been researched along with Cardiovascular Diseases in 279 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 112 (40.14) | 29.6817 |
| 2010's | 152 (54.48) | 24.3611 |
| 2020's | 15 (5.38) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnitcha, P; Fitzpatrick, M; Ireland, A; Koay, YC; Nguyen, VL; O'Sullivan, J; Sullivan, D | 1 |
| Chamienia, A; Dębska-Ślizień, A; Malgorzewicz, S; Puchalska-Reglińska, E; Wołoszyk-Chojecka, P | 1 |
| Andraweera, PH; Arstall, MA; Kosmider, L; Lassi, ZS; Tiong, P | 1 |
| Anderson, AH; Bhat, Z; Brown, J; Brunengraber, H; Charleston, J; Chen, J; Feldman, HI; He, J; Hostetter, TH; Hsu, CY; Ix, JH; Kimmel, PL; Mehta, R; Rao, P; Sapa, H; Schelling, JR; Schrauben, SJ; Seegmiller, JC; Shafi, T; Shlipak, MG; Townsend, R; Vasan, RS; Xie, D; Zhang, X | 1 |
| Al-Abdulla, N; Bakhsh, A; Mannocci, F; Moyes, D; Niazi, SA; Proctor, G | 1 |
| Bednarz-Misa, I; Bronowicka-Szydełko, A; Fleszar, MG; Gacka, M; Gamian, A; Kędzior, K; Krzystek-Korpacka, M; Masłowski, L; Wiśniewski, J; Witkiewicz, W | 1 |
| Bode-Böger, SM; Jarzebska, N; Mangoni, AA; Martens-Lobenhoffer, J; Rodionov, RN | 1 |
| Hu, W; Liu, T; Ma, Q; Wang, W; Zhang, J | 1 |
| Derkacz, A; Gać, P; Gocławska, K; Jurdziak, M; Mazur, G; Poręba, M; Poręba, R; Szuba, A; Trzmielewska, E | 1 |
| Doroszko, A; Gajecki, D; Gawrys, J; Szahidewicz-Krupska, E | 1 |
| Ashokachakkaravarthy, K; Mohan Raj, PS; Parameswaran, S; Priyadarshini, G; Priyadarssini, M; Rajappa, M; Revathy, G; Satheesh, S | 1 |
| Ochoa-Martínez, ÁC; Orta-García, ST; Pérez-Maldonado, IN; Varela-Silva, JA | 1 |
| Du, Q; Gao, J; Jin, Y; Lu, R; Yan, Y; Yu, C; Zou, Y | 1 |
| Dragičević, M; Košuta, I; Kruezi, E; Lovrenčić, MV; Mrzljak, A | 1 |
| Bakker, SJL; Bollenbach, A; Post, A; Tsikas, D | 1 |
| Charkiewicz, AE; Garley, M; Jabłońska, E; Maślach, D; Nowak, K; Omeljaniuk, WJ; Ratajczak-Wrona, W | 1 |
| Dai, Z; Fan, Y; Xiang, S; Zhang, H | 1 |
| Enko, D; März, W; Meinitzer, A; Pilz, S; Tomaschitz, A; Zelzer, S | 1 |
| Arós, F; Clish, CB; Corella, D; Estruch, R; Fitó, M; Gómez-Gracia, E; Guasch-Ferré, M; Hruby, A; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Toledo, E; Wang, DD; Yu, E | 1 |
| Berge, RK; Gaardbo, JC; Gerstoft, J; Hove-Skovsgaard, M; Kolte, L; Nielsen, SD; Seljeflot, I; Svardal, A; Trøseid, M; Ullum, H; Winding, K | 1 |
| Arya, S; Connelly, PW; Hanley, AJ; Retnakaran, R; Sermer, M; Ye, C; Zinman, B | 1 |
| Hsu, CN; Tain, YL | 1 |
| Alshahawey, M; Elsaid, TW; Sabri, NA; Shahin, SM | 1 |
| Singh, SA; Srinivasan, K; Venkatesh, R | 1 |
| Elliot, DJ; Hulin, JA; Lewis, BC; Mangoni, AA; McEvoy, M; Tommasi, S | 1 |
| Choi, HR; Jeon, DH; Kim, HC; Lee, SW; Yeom, H; Youm, Y | 1 |
| Javn, SB; Loganathan, S; Mala, K; Ramachandran, S; Sundari, M; Thomas, S | 1 |
| Almendarez-Reyna, CI; Ochoa-Martínez, ÁC; Orta-García, ST; Pérez-Maldonado, IN; Ruíz-Vera, T | 1 |
| Atzler, D; Böger, RH; Huisman, HW; Kruger, R; Malan, L; Malan, NT; Mels, CMC; Schutte, AE; Schwedhelm, E; Smith, W; van Rooyen, JM | 1 |
| Chen, XP; Hu, XL; Li, MP; Song, PY; Tang, J | 1 |
| Chang, J; Chen, JY; Hong, FF; Wang, XF; Yang, MW; Yang, SL; Ye, ZX; Zhong, HH | 1 |
| Bode-Böger, SM; Emrich, IE; Fliser, D; Heine, GH; Martens-Lobenhoffer, J; Wagenpfeil, S; Zawada, AM | 1 |
| Cardona-Lozano, ED; Carrizales-Yáñez, L; Ochoa-Martínez, ÁC; Pérez-Maldonado, IN | 1 |
| Feng, S; Li, H; Lu, X; Wang, F; Wang, S; Xiong, R | 1 |
| Aydogdu, A; Azal, O; Basaran, Y; Demir, O; Demirci, I; Dinc, M; Haymana, C; Meric, C; Sonmez, A; Torun, D; Yesildal, F | 1 |
| Batista, MC; Mayer, S; Quinto, BMR; Triches, CB; Zanella, MT | 1 |
| Aukrust, P; Gaardbo, JC; Gelpi, M; Gerstoft, J; Hoel, H; Holm, K; Hov, JR; Hove-Skovsgaard, M; Kummen, M; Nielsen, SD; Nwosu, F; Rudi, K; Seljeflot, I; Trøseid, M; Ueland, PM; Ullum, H; Valeur, J | 1 |
| Chandrasekharan, UM; Elaine Husni, M; Hazen, SL; Wang, S; Wang, Z; Wilson Tang, WH; Wu, Y | 1 |
| Briggs, WTE; Castro, C; FitzGerald, GA; Griffin, JL; Karlson, EW; Lahens, NF; Li, X; Malik, D; Meng, H; Rhoades, SD; Ricciotti, E; Sparks, JA; Tang, SY; Weljie, AM; West, JA | 1 |
| Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
| Kulwas, A; Rość, D; Wieczór, AM; Wieczór, R | 1 |
| Gouya, G; Litschauer, B; Ohrenberger, G; Sheikh Rezaei, S; Weisshaar, S; Wolzt, M | 1 |
| Almendarez-Reyna, CI; Carrizales-Yáñez, L; Ochoa-Martínez, ÁC; Pérez-Maldonado, IN; Ruiz-Vera, T; Zarazúa, S | 1 |
| Aleksandrowicz-Wrona, E; Dębska-Ślizień, A; Heleniak, Z; Lichodziejewska-Niemierko, M; Małgorzewicz, S; Rutkowski, R | 1 |
| Fujisawa, Y; Gohda, T; Horikoshi, S; Kobayashi, T; Nishiyama, A; Shiota, S; Sugaya, T; Suzuki, Y; Takahashi, K; Ueda, S | 1 |
| Fayh, APT; Krause, M; Rocha, IMGD; Rodrigues-Krause, J; Umpierre, D | 1 |
| Fromm, MF; König, J; Maas, R; Taghikhani, E | 1 |
| Bakker, SJL; Bollenbach, A; de Borst, MH; Frenay, AR; Kayacelebi, AA; Minović, I; Navis, G; Said, MY; Tsikas, D; van den Berg, E; van Goor, H; van Londen, M | 1 |
| Dimitroulas, T; Kitas, GD | 1 |
| Baamonde-Laborda, E; Gonzalez-Cabrera, F; Oliva-Damaso, E; Oliva-Damaso, N; Payan, J; Rodriguez-Esparragon, F; Rodriguez-Perez, JC; Santana-Estupiñan, R | 1 |
| Auge, D; Chafai, A; Fromm, MF; Gessner, A; Maas, R; Mieth, M; Müller, F | 1 |
| Linz, TH; Lunte, SM | 1 |
| Bitla, AR; Reddy, VS; Sachan, A; Srinivas Rao, PV; Suchitra, MM; Suresh, V; Tejovathi, B | 1 |
| Bouras, G; Deftereos, S | 1 |
| Bouras, G; Chatzis, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Stefanadis, C; Tousoulis, D; Tsounis, D | 1 |
| Bandinelli, S; D'Arrigo, G; Dattolo, P; Ferrucci, L; Maas, R; Michelassi, S; Mieth, M; Pizzarelli, F; Tripepi, G; Zoccali, C | 1 |
| Bogdanović, D; Cvetković, TP; Ignjatović, AM; Milošević, ZG; Pavlović, DD; Pavlović, RM; Stojanović, IR; Đorđević, VB; Đorđević, VM | 1 |
| Arefin, S; Carrero, JJ; Hammarqvist, F; Kublickiene, K; Näslund, E; Nordfors, L; Qureshi, AR; Rydén, M; Stenvinkel, P; Witasp, A | 1 |
| Cooke, JP; Erlanson, DA; Ghebremariam, YT; Lee, JC; Leiper, J; LePendu, P; Shah, NH; Slaviero, A | 1 |
| Ajisaka, R; Eto, M; Kumagai, H; Maeda, S; Miyaki, A; So, R; Tanaka, K | 1 |
| Chang, SL; Chao, TF; Chen, SA; Hsieh, MH; Hu, YF; Lin, YJ; Lo, LW; Lu, TM; Tsao, HM; Tuan, TC | 1 |
| Boeger, RH; Hamer, M; Lambert, GW; Malan, L; Malan, NT; Reimann, M; Schlaich, MP; Ziemssen, T | 1 |
| Anderssohn, M; Atzler, D; Ayers, CR; Böger, RH; de Lemos, JA; Gore, MO; Grant, PJ; Khera, A; Lüneburg, N; McGuire, DK; Schwedhelm, E | 1 |
| Hudson, CL; Ipp, H; Zemlin, AE | 1 |
| Ajjan, R; Anderssohn, M; Böger, RH; Grant, PJ; Lüneburg, N; McLachlan, S; Price, JF; Robertson, C; Schwedhelm, E; Strachan, MW; Williamson, RM | 1 |
| Bramlage, C; Konstantinides, S; Koziolek, MJ; Mueller, GA; Puls, M; Strauchmann, J; Wallbach, M | 1 |
| Chiarelli, F; Chiavaroli, V; de Giorgis, T; Diesse, L; Giannini, C; Marcovecchio, ML; Mohn, A | 1 |
| Dimitroulas, T; Kitas, GD; Sandoo, A; Smith, JP | 1 |
| Abd El Dayem, SM; Battah, AA; El Bohy, Ael M; El-Shehaby, A | 1 |
| Baranyi, A; Kapfhammer, HP; Meinitzer, A; Putz-Bankuti, C; Rothenhäusler, HB; Stauber, R | 1 |
| Ahmadi, Y; Badalzadeh, R; Faghfoori, Z; Ghavimi, H; Jabbarpour, M; Karami, H; Majidinia, M; Samadi, N; Shafiei-Irannejad, V; Yousefi, B | 1 |
| Bode-Böger, SM; Fliser, D; Kielstein, JT; Schepers, E; Speer, T | 1 |
| Atzler, D; Böger, RH; Dörr, M; Friedrich, N; Kroemer, HK; Nauck, M; Schwedhelm, E; Völker, U; Völzke, H; Wallaschofski, H | 1 |
| Beckmann, B; Gutzki, FM; Jordan, J; Kayacelebi, AA; Tsikas, D | 1 |
| Atzler, D; Böger, RH; Friedrich, N; Ittermann, T; Nauck, M; Schwedhelm, E | 1 |
| Aukrust, P; Consoli, A; Davì, G; Di Fulvio, P; Formoso, G; Lattanzio, S; Liani, R; Santilli, F; Ueland, T; Vazzana, N | 1 |
| Chan, WP; Chirkov, YY; Horowitz, JD; Ngo, DT; Sverdlov, AL | 1 |
| Doerfer, J; Grulich-Henn, J; Grünert, SC; Holder, M; Krebs, A; Lichte, K; Schmidt-Trucksäss, A; Schwab, KO; Stier, B; Winkler, K; Wöhrl, J | 1 |
| Dimitroulas, T; Douglas, KM; Hodson, J; Kitas, GD; Sandoo, A; Smith, JP | 1 |
| Bilge, AK; Caliskan, Y; Deniz, G; Ozkok, A; Sariyar, M; Yildiz, A; Yilmaz, A; Yilmaz, BA | 1 |
| Gerstoft, J; Kvale, D; Manner, IW; Nielsen, SD; Os, I; Pedersen, KK; Seljeflot, I; Trøseid, M | 1 |
| Alpoim, PN; Dusse, LM; Mota, AP; Rios, DR; Sousa, LP | 1 |
| Ahmetaj-Shala, B; Al'Yamani, M; Armstrong, PC; Kirkby, NS; Knowles, R; Leiper, J; Mackenzie, L; Mazi, S; Mitchell, JA; Nüsing, RM; Tomlinson, JA; Tucker, AT; Wang, Z; Warner, TD | 1 |
| Cefle, A; Kir, HM; Sahin, T; Unlu, BÖ; Yilmazer, B | 1 |
| Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S; Perkmann, T; Seidinger, D; Steiner, S | 1 |
| Cetinkaya, H; Eyileten, T; Gok, M; Haymana, C; Karaman, M; Oguz, Y; Rizzo, M; Saglam, M; Sonmez, A; Toth, PP; Unal, HU; Vural, A; Yilmaz, MI | 1 |
| Kaneko, K; Kuroyanagi, Y; Takaya, J; Tanabe, Y | 1 |
| Akilli, H; Alibasic, H; Aribas, A; Gunduz, M; Kayrak, M; Taner, A; Tekinalp, M; Unlu, A; Yildirim, S | 1 |
| Chowdhury, R; Chowdhury, S; Di Angelantonio, E; Freitag, DF; Gobin, R; Laukkanen, JA; Mayr, M; Willeit, P | 1 |
| İn, E; Kaman, D; Özdemir, C; Sökücü, SN | 1 |
| Georgakis, MK; Latsios, G; Oikonomou, E; Papageorgiou, N; Papaioannou, S; Siasos, G; Tousoulis, D; Zaromitidou, M | 1 |
| Atzler, D; Baum, C; Blankenberg, S; Böger, RH; Gori, T; Johannsen, SS; Lackner, KJ; Münzel, T; Ojeda, FM; Schnabel, RB; Schwedhelm, E; Sinning, CR; Wild, PS; Zeller, T | 1 |
| Banderali, G; Cefalo, G; Giovannini, M; Lassandro, C; Moretti, F; Radaelli, G; Salvatici, E; Verduci, E | 1 |
| Aly, H; El Melegy, S; El Shikh, T; El-Batch, M; Rowisha, M | 1 |
| Antonelli-Incalzi, R; Battistoni, F; Chiurco, D; Costanzo, L; Pedone, C; Santangelo, S | 1 |
| Afsar, B; Covic, A; Eyileten, T; Gezer, M; Johnson, RJ; Kanbay, M; Karaman, M; Oguz, Y; Ortiz, A; Saglam, M; Siriopol, D; Unal, HU; Verim, S; Vural, A; Yilmaz, MI | 1 |
| Chrysis, D; Efthymiadou, A; Kritikou, D; Mermigka, A; Spiliotis, BE | 1 |
| Guo, BC; Hsu, CP; Lee, TS; Lin, SJ; Lu, TM; Shyue, SK; Zhao, JF | 1 |
| Chybicka, A; Doroszko, A; Jakubowski, M; Mazur, G; Niedzielska, E; Porwolik, J; Szahidewicz-Krupska, E; Szuba, A; Turek-Jakubowska, A | 1 |
| Boaz, M; Ganz, T; Gilad, S; Limor, R; Stern, N; Wainstein, J | 1 |
| Chen, XL; Gao, XR; Lao, MC; Liu, LJ; Lu, GH; Luo, CF; Zhai, YS | 1 |
| Bode-Böger, SM; Bornstein, SR; Brilloff, S; Brocker, C; Burdin, DV; Demyanov, AV; Gonzalez, F; Jarzebska, N; Kolobov, AA; Maas, R; Martens-Lobenhoffer, J; Mieth, M; Rodionov, RN; Samusik, N; Soshnev, AA; Weiss, N | 1 |
| Banerjee, T; Coresh, J; Hai, X; Hostetter, TH; Hwang, S; Melamed, ML; Meyer, TW; Powe, NR; Shafi, T | 1 |
| Abe, Y; Arai, Y; Hirata, T; Ohkuma, K; Takayama, M; Takebayashi, T | 1 |
| Gongora, E; Nair, N | 1 |
| Abdel Hamid, SG; El-Mesallamy, HO; Gad, MZ | 1 |
| Alfthan, G; Hutri-Kähönen, N; Jula, A; Juonala, M; Kähönen, M; Laaksonen, R; Lehtimäki, T; Päivä, H; Raitakari, OT; Viikari, J | 1 |
| Zsuga, J | 1 |
| Alchanatis, M; Dimitriadis, K; Kallikazaros, I; Manolis, A; Stefanadis, C; Thomopoulos, C; Tousoulis, D; Tsiachris, D; Tsioufis, C | 1 |
| Aso, Y | 1 |
| Kaida, Y; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, S | 1 |
| Krzyzanowska, K; Mittermayer, F; Wolzt, M | 1 |
| Getino, MA; Jarque, A; Lozano, L; Mora-Fernández, C; Navarro, JF; Sánchez, R | 1 |
| Agustí, AG; Alonso, A; Ayllón, O; Barceló, A; de la Peña, M; González, C; Pérez, G; Piérola, J; Vega-Agapito, MV | 1 |
| Yilmaz, MB; Yontar, OC | 1 |
| Krzyzanowska, K; Mittermayer, F; Schernthaner, G; Wolzt, M | 2 |
| Bode-Böger, SM; Ertl, T; Lakatos, O; Martens-Lobenhoffer, J; Sulyok, E; Vida, G | 1 |
| Celik, T; Iyisoy, A; Jata, B; Yuksel, C | 1 |
| Egger, G; Holt, DW; Kiechl, S; Lee, T; Mayr, M; Santer, P; Thompson, G; Tsimikas, S; Willeit, J; Xu, Q | 1 |
| Mallamaci, F; Zoccali, C | 1 |
| Benjamin, EJ; Benndorf, RA; Böger, RH; Maas, R; Schulze, F; Schwedhelm, E; Sullivan, LM; Vasan, RS; Wang, TJ; Xanthakis, V | 1 |
| Mangoni, AA; Wadham, C | 1 |
| Bianchi, M; De Gennaro Colonna, V; Ferrario, P; Morelli, F; Pascale, V; Pascale, W; Tomasoni, L; Turiel, M | 1 |
| Ayer, JG; Celermajer, DS; Harmer, JA; Marks, GB; Nakhla, S; Ng, MK; Raitakari, OT; Xuan, W | 1 |
| Benndorf, RA; Böger, RH; Maas, R; Riederer, U; Schulze, F; Schwedhelm, E; Sullivan, LM; Vasan, RS; Xanthakis, V | 1 |
| Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z | 1 |
| Böger, RH; Maas, R; Schulze, F; Schwedhelm, E | 2 |
| Fuchs, D; Kurz, K; Sarcletti, M; Teerlink, T; Weiss, G; Zangerle, R | 1 |
| Chirkov, YY; Horowitz, JD; McNeil, JJ; Ngo, DT; Nightingale, AK; Sverdlov, AL; Willoughby, SR | 1 |
| Cardounel, AJ; Karuppiah, K; Pope, AJ | 1 |
| Luo, Z; Palm, F; Teerlink, T; Wilcox, CS | 1 |
| Mangoni, AA | 1 |
| Abedini, S; Fellstrøm, B; Holdaas, H; Holme, I; Jardine, A; März, W; Meinitzer, A; Weihrauch, G | 1 |
| Böger, RH | 7 |
| Fair, JM; Fortmann, SP; Go, AS; Hlatky, MA; Iribarren, C; Sydow, K; Tsao, PS; Varady, A | 1 |
| Blackwell, S | 1 |
| Bode-Böger, SM; David, S; Fliser, D; Haller, H; Kielstein, JT; Kliem, V; Kümpers, P; Lukasz, A; Martens-Lobenhoffer, J | 1 |
| Förstermann, U | 1 |
| Arend, M; Atzler, D; Böger, RH; Cardounel, AJ; Cordasic, N; Heusinger-Ribeiro, J; Hilgers, KF; Jacobi, J; Maas, R; Pope, AJ; Schwedhelm, E; Strobel, J | 1 |
| Evans, A; Gey, KF; Gilchrist, SE; McKinley, MC; O'Doherty, MG; Skidmore, PM; Woodside, JV; Yarnell, JW; Young, IS | 1 |
| Dohi, Y; Ito, A; Itoh, T; Kajikuri, J; Koyama, K; Kumagai, H; Nakamura, H; Nishio, T; Ohte, N; Sano, A; Yamamoto, J | 1 |
| Ayhan, SS; Bacaksiz, A; Kayrak, M; Taner, A; Ulgen, MS; Unlü, A; Vatankulu, MA; Yazici, M | 1 |
| Azqueta, M; Cases, A; Coll, E; Collado, S; Cruzado, JM; de la Torre, B; Deulofeu, R; Guerrero, L; Nicolau, C; Pons, M; Vera, M | 1 |
| Artusi, C; Boffa, GM; Ivanova, M; Plebani, M; Zaninotto, M | 1 |
| Berta, A; Biri, B; Bodnár, N; Gesztelyi, R; Kéki, S; Kemény-Beke, Á; Kerekes, G; Szántó, S; Szekanecz, Z; Szodoray, P; Zsuga, J; Zsuga, M | 1 |
| Aleksandrowicz-Wrona, E; Lichodziejewska-Niemierko, M; Małgorzewicz, S; Rutkowski, B; Świetlik, D; Łysiak-Szydłowska, W | 1 |
| Alfthan, G; Hutri-Kähönen, N; Juonala, M; Kähönen, M; Laaksonen, R; Laitinen, T; Lehtimäki, T; Päivä, H; Raitakari, OT; Taittonen, L; Viikari, J | 1 |
| Engin-Üstün, Y; Kafkasli, A; Kali, Z; Karabulut, AB; Meydanli, M; Turan, F; Türkçüoğlu, I | 1 |
| Ayhan, S; Demir, K; Erdem, S; Karabag, T; Kaya, A; Kaya, C; Koc, F; Tokac, M; Unlu, A; Vatankulu, MA | 1 |
| Boehm, BO; Drechsler, C; Kielstein, JT; März, W; Meinitzer, A; Pilz, S; Ritz, E; Winkelmann, BR | 1 |
| Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
| Kanazawa, I; Nabika, T; Notsu, Y; Sugimoto, T; Yamaguchi, T; Yano, S | 1 |
| Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B | 1 |
| Ahmetaj, B; Arrigoni, F; Leiper, J | 1 |
| Dalton, RN; Dunger, DB; Marcovecchio, ML; Turner, C; Widmer, B | 1 |
| Chung, MY; Hsu, CP; Lin, MW; Lin, SJ; Lu, TM | 2 |
| Jin, LJ; Li, X; Tse, HF | 1 |
| Jackson, G; Wierzbicki, AS | 1 |
| Aggelis, A; Alexopoulos, N; Ioakeimidis, N; Rokkas, K; Samentzas, A; Stefanadis, C; Terentes-Printzios, D; Vlachopoulos, C | 1 |
| Huang, LT; Tain, YL | 1 |
| Gu, LQ; Li, FY; Liu, JM; Liu, Y; Ning, G; Zhang, MJ; Zhao, L; Zhao, YJ; Zhu, W | 1 |
| Drexel, V; Emslander, I; Halle, M; Hanssen, H; Hertel, G; Kotliar, KE; Lorang, D; Nickel, T; Pressler, A; Schmidt-Trucksäss, A; Schuster, T; Sisic, Z; Weis, M | 1 |
| Aasarød, K; Åsberg, A; Bigonah, A; Hatlen, G; Hov, GG; Sagen, E | 1 |
| Atzler, D; Bache, RJ; Böger, RH; Chen, Y; Fassett, J; Guo, H; Hu, X; Lu, Z; Schwedhelm, E; Xu, X; Zhang, P | 1 |
| Cameron, JD; Moran, LJ; Strauss, BJ; Teede, HJ | 1 |
| Boger, R; Maas, R; Malatino, L; Mallamaci, F; Mattace Raso, F; Rapisarda, F; Seck, MS; Sijbrands, E; Tripepi, G; Witteman, J; Zoccali, C | 1 |
| Cooke, JP; Ghebremariam, YT | 1 |
| Bogner, M; Elmadfa, I; Fabian, E | 1 |
| Agusti, AG; Alonso, A; Ayllón, O; Barbè, F; Barceló, A; de la Peña, M; Esquinas, C; Piérola, J; Sanchez-de la Torre, M | 1 |
| Oikonomou, E; Papageorgiou, N; Papavassiliou, AG; Siasos, G; Stefanadis, C; Stougianos, P; Tousoulis, D | 1 |
| Bicchieri, L; Di Gennaro, C; Manfredi, G; Montanari, A; Palombi, F; Pellegrino, A; Pinelli, S; Saccani-Jotti, G; Sansoni, P; Venturi, N | 1 |
| Atzler, D; Baldus, S; Blankenberg, S; Böger, RH; D'Alecy, LG; Ehmke, H; Gadegbeku, CA; Hellwinkel, O; Kielstein, JT; Klinke, A; Kubala, L; Lau, D; Lund, N; Maas, R; Meinertz, T; Pekarova, M; Schmidt-Haupt, R; Schwedhelm, E; Slocum, JL; Sydow, K; Tsikas, D; von Leitner, EC; Willems, S | 1 |
| Anderssohn, M; Böger, RH; Fourie, CM; Glyn, MC; Huisman, HW; Lüneburg, N; Malan, L; Malan, NT; Mels, CM; Schutte, AE; Schutte, R; Smith, W; Van Rooyen, JM | 1 |
| Wilcox, CS | 1 |
| Chen, J; Chen, R; Goligorsky, MS; Lu, CY; Moskowitz-Kassai, E; Sanduski, K; Špes, A; Turk, B; Xavier, S | 1 |
| Fijorek, K; Goralczyk, T; Tisonczyk, J; Undas, A | 1 |
| Alsagaff, MY; Aminuddin, M; Thaha, M; Tomino, Y; Yogiantoro, M; Yogiarto, RM | 1 |
| Caplin, B; Leiper, J | 1 |
| Kimura, K | 1 |
| Brinkworth, GD; Buckley, JD; Clifton, PM; Noakes, M; Norman, RJ; Thomson, RL | 1 |
| Derbent, A; Gumus, II; Karakurt, F; Kargili, A; Kasapoglu, B; Kaygusuz, I; Uysal, S | 1 |
| Wierzbicki, AS | 1 |
| Auge, D; Endress, B; Fromm, MF; König, J; Maas, R; Mieth, M; Strobel, J | 1 |
| Balwierz, W; Ćwiklińska, M; Grodzicki, TK; Gryglewska, B; Kwater, A; Strach, M; Sulicka, J; Surdacki, A | 1 |
| Clifton, PM; Moran, LJ; Noakes, M; Norman, RJ; Wittert, GA | 1 |
| Chen, XM; Hu, CP; Jiang, JL; Li, YJ | 1 |
| Ahmed, IK; Ali, SR; Elmageed, AM; Saleh, BI | 1 |
| Aldámiz-Echevarría, L; Andrade, F | 1 |
| Angelidi, A; Dimitriadis, G; Foussas, S; Gritzapis, A; Matsagos, S; Melidonis, A; Panoutsopoulos, GI; Protopsaltis, I; Raptis, S; Sergentanis, TΝ; Tzirogiannis, K | 1 |
| Aydin, Z; Gurdal, A; Gursu, M; Karadag, S; Kazancioglu, R; Koldas, M; Kumbasar, B; Ozturk, S; Uzun, S; Yegen, M | 1 |
| Dimitroulas, T; Kitas, GD; Sandoo, A | 1 |
| Gao, Y; Vanhoutte, PM | 1 |
| Attia, JR; Carru, C; Mangoni, AA; McEvoy, M; Zinellu, A | 1 |
| Fujiwara, N; Nakamura, M; Okumura, K; Osanai, T; Osawa, H; Saitoh, M; Sasaki, S; Tomita, H; Yamabe, H | 1 |
| Zoccali, C | 3 |
| Hansson, L; Hedner, T; Himmelmann, A | 1 |
| Chan, JC; Chan, NN | 1 |
| de Jong, S; Neele, SJ; Netelenbos, JC; Stehouwer, CD; Teerlink, T | 1 |
| Bode-Böger, SM; Fliser, D; Haller, H; Kielstein, JT | 1 |
| Bonfigli, AR; Coppa, G; Gambini, A; Marra, M; Testa, I; Testa, R | 1 |
| Kenemans, P; Post, MS; Stehouwer, CD; Teerlink, T; van der Mooren, MJ; Verhoeven, MO | 1 |
| Magota, K; Murakami, S; Nakamura, M; Okumura, K; Osanai, T; Osawa, H; Saitoh, M; Sasaki, S; Tomita, H; Yamabe, H | 1 |
| Böger, RH; Cooke, JP; Vallance, P | 1 |
| Böger, RH; Zoccali, C | 1 |
| Münzel, T; Sydow, K | 1 |
| Cooke, JP | 3 |
| Dayal, S; Lentz, SR; Rodionov, RN | 1 |
| Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
| Cooke, JP; Gao, SZ; Kledal, TN; Lin, KY; Mocarski, ES; Panchal, SN; Valantine, HA; Weis, M | 1 |
| Leiper, J; Vallance, P | 1 |
| Laaksonen, R; Valkonen, VP | 1 |
| Yoshizumi, M | 1 |
| Böger, RH; Ron, ES | 1 |
| Brodsky, SV; Chen, J; Goligorsky, MS; Li, H; O'Riordan, E; Smirnova, I | 1 |
| Cutrupi, S; Malatino, LS; Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
| Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS | 1 |
| Enia, G; Mallamaci, F; Panuccio, V; Tripepi, G; Zoccali, C | 1 |
| Akgul, EO; Beyhan, Z; Bilgi, C; Cakir, E; Erbil, MK; Erturk, K; Ozcan, O; Yaman, H | 1 |
| Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Jachmann, N; Lackner, KJ; Lubos, E; Münzel, T; Peetz, D; Post, F; Rupprecht, HJ; Schnabel, R; Tiret, L | 1 |
| Bultink, IE; Dijkmans, BA; Heijst, JA; Teerlink, T; Voskuyl, AE | 1 |
| Kielstein, JT; Zoccali, C | 2 |
| Boeger, R; Fatuzzo, P; Maas, R; Malatino, L; Mallamaci, F; Spoto, B; Testa, A; Tripepi, G; Zoccali, C | 1 |
| Böger, RH; Freese, R; Maas, R; Schulze, F; Schwedhelm, E; Silberhorn, E | 1 |
| Anthony, S; Hubank, M; Leiper, JM; Smith, CL; Vallance, P | 1 |
| Teerlink, T | 1 |
| Bauersachs, J; Thum, T | 1 |
| Markov, KhM | 1 |
| Acikel, C; Aydin, A; Caglar, K; Cakir, E; Erbil, K; Eyileten, T; Genctoy, G; Ozcan, O; Ozgurtas, T; Saglam, M; Sonmez, A; Tasar, M; Vural, A; Yilmaz, MI; Zoccali, C | 1 |
| Grdić, M; Huber, K; Maurer, G; Niessner, A; Penka, M; Richter, B; Simeon-Rudolf, V; Steiner, S; Strasser, B; Wojta, J; Ziegler, S; Zorn, G | 1 |
| Dayal, S; Lentz, SR | 1 |
| Cooke, JP; Mondon, CE; Sydow, K | 1 |
| Laaksonen, R; Tuomainen, TP; Valkonen, VP | 1 |
| Maas, R | 1 |
| Cambou, JP; Cottin, Y; Danchin, N; Empana, JP; Ferrières, J; Jouven, X; Paillard, F; Thomas, D; Valensi, P; Zeller, M | 1 |
| Brouwer, CB; Rauwerda, JA; Smulders, YM; Spoelstra-de Man, AM; Stehouwer, CD; Teerlink, T | 1 |
| Cibulka, R; Racek, J; Rajdl, D; Siroká, R | 1 |
| Branca, F; Bugel, S; Dahlman-Wright, K; Dierkes, J; Ferrari, M; Hall, WL; Hallund, J; Huebner, U; Koebnick, C; Nilsson, M; Reimann, M; Vafeiadou, K; Williams, CM | 1 |
| Goss, M; Kopieczna-Grzebieniak, E | 1 |
| Barth, SW; Bub, A; Hahn, A; Hülsmann, O; Kressel, G; Kühn-Velten, WN; Lichtinghagen, R; Schmitt, B; Stichtenoth, DO; Ströhle, A; Wolters, M | 1 |
| Hirata, Y | 1 |
| Amighi, J; Exner, M; Krzyzanowska, K; Minar, E; Mittermayer, F; Mlekusch, W; Müller, M; Sabeti, S; Schillinger, M; Wolzt, M | 1 |
| Baylis, C | 1 |
| Hishida, A; Ikegaya, N; Kato, A; Kumagai, H; Maruyama, Y; Sakurai, M; Takita, T; Uno, S | 1 |
| Boehm, BO; Halwachs-Baumann, G; März, W; Meinitzer, A; Seelhorst, U; Wellnitz, B; Winkelmann, BR | 1 |
| Cooke, JP; Kielstein, JT | 1 |
| Podgórski, M; Szuba, A | 1 |
| Ardigo, D; Franzini, L; Pachinger, O; Piatti, PM; Reaven, GM; Stüehlinger, M; Valtueña, S; Zavaroni, I | 1 |
| Fliser, D; Kielstein, JT | 1 |
| Böger, RH; Dentz, L; Haddad, M; Hiltmeyer, N; Klöss, T; Kuss, O; Maas, R; Schwedhelm, E; Standl, T; Thoms, W | 1 |
| Smith, CL | 1 |
| Fukami, K; Matsumoto, Y; Okuda, S; Ueda, S; Yamagishi, SI | 1 |
| Lipman, ML; Mann, JF; Schiffrin, EL | 1 |
| Durante, W; Johnson, FK; Johnson, RA | 1 |
| Alfthan, G; Juonala, M; Kähönen, M; Laitinen, T; Marniemi, J; Raitakari, OT; Taittonen, L; Viikari, JS | 1 |
| Bekpinar, S; Can, A; Cetinalp-Demircan, P; Orhan, Y; Unlucerci, Y | 1 |
| Blankenberg, S; Schnabel, R | 1 |
| Baysal, E; Maden, O; Ozeke, O; Sasmaz, A; Selcuk, H; Selcuk, MT; Temizhan, A; Ulupinar, H | 1 |
| Luo, Z; Onozato, ML; Palm, F; Wilcox, CS | 1 |
| Arning, E; Bottiglieri, T; Cooke, JP; Dayoub, H; Faraci, FM; Lentz, SR; Lynch, C; Rodionov, RN | 1 |
| Andreotti, F; Coluzzi, G; Marzo, F; Santucci, E | 1 |
| Axelsson, J; Carrero, JJ; Heimbürger, O; Lindholm, B; Massy, Z; Stenvinkel, P | 1 |
| Boeger, RH; Deussen, A; Henle, T; Pexa, A; Schwedhelm, E | 1 |
| Lentz, SR; Rodionov, RN | 1 |
| Abbasi, F; Chu, JW; Cooke, JP; Lamendola, C; McLaughlin, TL; Reaven, GM; Stühlinger, MC; Tsao, PS | 1 |
| Nash, DT | 1 |
88 review(s) available for n,n-dimethylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Asymmetric dimethylarginine and gestational diabetes mellitus: a systematic review and meta-analysis.
Topics: Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Humans; Postpartum Period; Pregnancy | 2023 |
The Second Life of Methylarginines as Cardiovascular Targets.
Topics: Amidohydrolases; Animals; Arginine; Biological Transport; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Disease Susceptibility; Energy Metabolism; Humans; Molecular Targeted Therapy | 2019 |
Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders.
Topics: Amidohydrolases; Arginine; Blood Platelets; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Networks and Pathways; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2020 |
Asymmetric dimethylarginine level as biomarkers of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Humans; Mortality; Renal Insufficiency, Chronic | 2021 |
Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Energy Metabolism; Humans; Nitric Oxide; Nutritional Physiological Phenomena; Oxidative Stress; Reactive Oxygen Species; Signal Transduction | 2017 |
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Homocysteine; Humans; Oxidative Stress; Polycystic Ovary Syndrome; Receptor for Advanced Glycation End Products; von Willebrand Factor | 2017 |
AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems.
Topics: Animals; Arginine; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney Diseases; Transaminases | 2017 |
Nitric oxide bioavailability dysfunction involves in atherosclerosis.
Topics: Animals; Arginine; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Obesity; Oxidative Stress; Smoking; Vasodilation | 2018 |
Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Humans; Renal Insufficiency, Chronic | 2018 |
Asymmetric dimethylarginine and angiogenesis: biological significance.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Signal Transduction; Up-Regulation | 2018 |
Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Dietary Supplements; Endothelium, Vascular; Female; Humans; Hyperemia; Male; Middle Aged; Nitrates; Nitrites; Obesity; Treatment Outcome | 2018 |
Genetic regulation of dimethylarginines and endothelial dysfunction in rheumatoid arthritis.
Topics: Arginine; Arthritis, Rheumatoid; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Humans; Inflammation; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Transaminases | 2019 |
Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach.
Topics: Aging; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Networks and Pathways; Molecular Targeted Therapy; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic | 2019 |
Asymmetric Dimethylarginine (ADMA): a promising biomarker for cardiovascular disease?
Topics: Aging; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Diabetes Complications; Enzyme-Linked Immunosorbent Assay; Humans; Hypertension; Mass Spectrometry; Nitric Oxide; Oxidative Stress; Reference Values; Risk Factors; Smoking | 2013 |
Is asymmetric dimethylarginine associated with being born small and large for gestational age?
Topics: Arginine; Biomarkers; Birth Weight; Cardiovascular Diseases; Female; Gestational Age; Humans; Metabolic Diseases; Pregnancy | 2014 |
Dimethylarginines ADMA and SDMA: the real water-soluble small toxins?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Humans; Kidney Diseases; Water | 2014 |
Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease.
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Nitric Oxide Synthase; Proteinuria | 2015 |
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.
Topics: Arginine; Cardiovascular Diseases; Humans; Odds Ratio; Prospective Studies; Stroke | 2015 |
Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches.
Topics: Alzheimer Disease; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypercholesterolemia; Neoplasms; Pre-Eclampsia; Pregnancy; Renal Insufficiency, Chronic | 2015 |
Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
Topics: Adiponectin; Arginine; Blood Pressure; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Diet; Homocysteine; Humans; Oxidative Stress; Pediatric Obesity; Phenylalanine; Phenylketonurias; Risk Factors | 2016 |
Oxidative Stress and Cardiovascular Aging: Interaction Between NRF-2 and ADMA.
Topics: Aging; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction | 2017 |
Cardiovascular disease in patients with diabetic nephropathy.
Topics: Anemia; Arginine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Homocysteine; Humans; Prognosis; Risk Factors | 2008 |
[Endothelial injury and CKD].
Topics: Animals; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Risk Factors | 2008 |
[Asymmetric dimethylarginine (ADMA): A cardiovascular risk factor].
Topics: Adult; Arginine; Austria; Biomarkers; Cardiovascular Diseases; Humans; Male; Prevalence; Risk Assessment; Risk Factors | 2008 |
[Novelties in the field of progression factors in chronic kidney disease].
Topics: Adult; Amidohydrolases; Animals; Arginine; Carbon; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Disease Progression; Female; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infant, Low Birth Weight; Infant, Newborn; Kidney Diseases; Male; Oxides; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Uremia; Uric Acid | 2008 |
ADMA, cardiovascular disease and diabetes.
Topics: Arginine; Cardiovascular Diseases; Diabetes Mellitus; Humans; Models, Biological | 2008 |
Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Agents; Cardiovascular Diseases; Disease Progression; Drug Delivery Systems; Gene Expression Regulation, Enzymologic; Humans; Nitric Oxide | 2009 |
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.
Topics: Animals; Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Kidney; Nitric Oxide Synthase; Risk Factors | 2009 |
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality--an update on patient populations with a wide range of cardiovascular risk.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Prospective Studies; Risk Factors | 2009 |
Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Protein-Arginine N-Methyltransferases | 2009 |
Cellular ADMA: regulation and action.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide Synthase; Signal Transduction | 2009 |
The emerging role of symmetric dimethylarginine in vascular disease.
Topics: Arginine; Cardiovascular Diseases; Homeostasis; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Renal Insufficiency | 2009 |
The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biochemistry; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Metabolic Clearance Rate; Models, Biological; Nitric Oxide Synthase; Oxidative Stress; Prognosis | 2010 |
Nitric oxide and oxidative stress in vascular disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Biopterins; Calcium; Cardiovascular Diseases; Catalase; Electron Transport; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondria; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Multimerization; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Superoxide Dismutase; Superoxides; Thioredoxins; Vascular Diseases; Xanthine Oxidase | 2010 |
The biology and therapeutic potential of the DDAH/ADMA pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Molecular Targeted Therapy; Nitric Oxide; Nitric Oxide Synthase | 2010 |
Novel endothelial biomarkers: implications for periodontal disease and CVD.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cell-Derived Microparticles; Endothelial Cells; Endothelium, Vascular; Gingivitis; Humans; Nitric Oxide Synthase; Periodontitis; Stem Cells | 2011 |
Asymmetric dimethylarginine: clinical applications in pediatric medicine.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Child, Preschool; Endothelium, Vascular; Enzyme Inhibitors; Humans; Infant; Nitric Oxide Synthase; Pediatrics; Reference Values; Risk Factors | 2011 |
Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Humans; Kidney Diseases; Rats; Reactive Oxygen Species; Risk Factors | 2012 |
Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators?
Topics: Amidohydrolases; Animals; Arginine; Binding Sites; Binding, Competitive; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases; Catalytic Domain; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine | 2012 |
[Methylarginies-induced endothelial dysfunction in chronic kidney disease].
Topics: Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Renal Insufficiency, Chronic; Risk Factors | 2012 |
New directions in cardiovascular risk assessment: the role of secondary risk stratification markers.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adrenomedullin; Ankle Brachial Index; Arginine; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Early Diagnosis; Humans; Lipoprotein(a); Natriuretic Peptide, Brain; Peptide Fragments; Protein Precursors; Risk Assessment; Troponin; Vascular Calcification; Vasodilation | 2012 |
Cardiovascular risk in autoimmune disorders: role of asymmetric dimethylarginine.
Topics: Animals; Arginine; Autoimmune Diseases; Cardiovascular Diseases; Humans; Risk | 2012 |
Asymmetric dimethylarginine, endothelial dysfunction and renal disease.
Topics: Adult; Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Child; Disease Progression; Endothelial Cells; Endothelium, Vascular; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Nitric Oxide; Oxidative Stress; Risk Factors | 2012 |
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Rheumatic Diseases; Risk Factors | 2012 |
Beta blockers, nitric oxide, and cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Arginine; Cardiovascular Diseases; Humans; Nitric Oxide; Vasodilation | 2013 |
Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Metabolic Syndrome | 2002 |
[Cardiovascular events in chronic advanced renal insufficiency. Current concepts].
Topics: Anemia; Arginine; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Inflammation; Kidney Failure, Chronic; Nitric Oxide Synthase; Risk Factors; Sleep Apnea Syndromes; Smoking | 2003 |
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
Topics: Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Risk Factors | 2003 |
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor.
Topics: Amidohydrolases; Arginine; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Risk Factors | 2003 |
ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Kidney Failure, Chronic; Nitric Oxide Synthase; Risk Factors | 2003 |
ADMA and oxidative stress.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Oxidative Stress; Vasodilation | 2003 |
NO and angiogenesis.
Topics: Angiogenesis Inhibitors; Arginine; Cardiovascular Diseases; Cell Movement; Cell Survival; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide | 2003 |
Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hyperhomocysteinemia; Risk Factors | 2003 |
Novel cardiovascular risk factors in end-stage renal disease.
Topics: Arginine; Calcinosis; Cardiovascular Diseases; Humans; Hypertension; Inflammation; Kidney Failure, Chronic; Nitric Oxide Synthase; Oxidative Stress; Risk Factors | 2004 |
Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications.
Topics: Animals; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide Synthase; Up-Regulation | 2003 |
[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Child; Coronary Disease; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Free Radicals; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Nitric Oxide Synthase; Oxidative Stress; Pre-Eclampsia; Pregnancy; Prospective Studies; Rabbits; Regression Analysis; Renal Dialysis; Risk Factors; Stroke | 2004 |
Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Mice; Models, Biological; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Pre-Eclampsia; Pregnancy; Protein-Arginine N-Methyltransferases; Renal Insufficiency | 2004 |
The pivotal role of nitric oxide for vascular health.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Disease Progression; Endothelium, Vascular; Female; Homeostasis; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Survival Analysis | 2004 |
Asymmetric dimethylarginine (ADMA) and acute vascular events.
Topics: Acute Disease; Angina Pectoris; Arginine; Cardiovascular Diseases; Humans; Myocardial Infarction; Stroke | 2004 |
Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor.
Topics: Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Risk Factors | 2004 |
[Asymmetric dimethylarginine and endothelial dysfunction].
Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Hemodynamics; Humans; Methylation; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Renin-Angiotensin System | 2004 |
L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Topics: Arginine; Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III | 2005 |
Endothelial cell dysfunction: the syndrome in making.
Topics: Animals; Apoptosis; Arginine; Cardiovascular Diseases; Cellular Senescence; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Hyperhomocysteinemia; Kidney Diseases; Models, Biological; Oxidative Stress; Syndrome | 2005 |
Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients.
Topics: Arginine; Autonomic Nervous System Diseases; C-Reactive Protein; Cardiovascular Diseases; Humans; Hyperhomocysteinemia; Inflammation; Italy; Kidney Failure, Chronic; Nitric Oxide Synthase; Norepinephrine; Peritoneal Dialysis; Risk Factors | 2005 |
Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Stenosis; Cross-Sectional Studies; Endocrine System Diseases; Endothelium, Vascular; Haplorhini; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Rats; Rats, Inbred Dahl; Renal Dialysis; Risk Factors; Sodium Chloride, Dietary; Tunica Intima; Tunica Media; Uremia | 2005 |
Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Prognosis | 2005 |
Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.
Topics: Animals; Arginine; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors; Sensitivity and Specificity | 2005 |
[Molecular mechanisms of dysfunction of vascular endothelium].
Topics: Adult; Animals; Apoptosis; Arginine; Atherosclerosis; Cardiovascular Diseases; Cells, Cultured; Child; Endothelial Cells; Endothelin-1; Endothelium, Vascular; Epoprostenol; Female; GTP-Binding Proteins; Hemodynamics; Humans; Macrophages; Male; Multienzyme Complexes; Mutation; NADH, NADPH Oxidoreductases; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Pregnancy; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Risk Factors; RNA, Messenger | 2005 |
ADMA: its role in vascular disease.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Mice; Mice, Transgenic; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2005 |
Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Enzyme Inhibitors; Humans; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Vasodilation | 2005 |
ADMA and hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Nitric Oxide Synthase Type III; Risk Factors; Superoxides; Vasodilation | 2005 |
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
Topics: Animals; Arginine; Cardiovascular Diseases; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase; Randomized Controlled Trials as Topic; Risk Factors; Vasodilation | 2005 |
DDAH gene and cardiovascular risk.
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Humans; Hypertension; Male; Mutation; Polymorphism, Genetic; Risk Factors | 2005 |
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Topics: Amidohydrolases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Nitric Oxide; Nitric Oxide Synthase; Protein-Arginine N-Methyltransferases; Renal Insufficiency | 2005 |
[The best of epidemiology and cardiovascular prevention in 2005].
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Complications; Environmental Pollutants; Humans; Metabolic Syndrome; Publishing; Risk Factors; Smoking | 2006 |
Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move.
Topics: Arginine; Cardiovascular Diseases; Humans; Renal Insufficiency; Risk Factors | 2006 |
[Asymmetric dimethylarginine--a novel cardiovascular risk factor].
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Vasodilation | 2006 |
[The importance of regulation of endogenous methylarginine concentrations in clinical practice].
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Humans; Protein-Arginine N-Methyltransferases | 2005 |
[Nitric oxide].
Topics: Adiponectin; Aldosterone; Animals; Arginine; Blood Pressure; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase Type III; Stem Cells; Stress, Mechanical | 2006 |
Arginine, arginine analogs and nitric oxide production in chronic kidney disease.
Topics: Absorption; Amidohydrolases; Arginine; Biological Availability; Cardiovascular Diseases; Chronic Disease; Comorbidity; Enzyme Inhibitors; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Genetic | 2006 |
Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Cross-Sectional Studies; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Risk Factors | 2006 |
The past, presence and future of ADMA in nephrology.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Kidney Diseases; Kidney Function Tests; Nitric Oxide Synthase; Risk Factors | 2007 |
C-reactive protein and asymmetric dimethylarginine: markers or mediators in cardiovascular disorders?
Topics: Animals; Arginine; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Humans; Inflammation; Nitric Oxide; Risk Assessment; Risk Factors | 2007 |
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
Topics: Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase | 2007 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors | 2007 |
Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Topics: Animals; Arginase; Arginine; Cardiovascular Diseases; Cell Proliferation; Collagen; Endothelium, Vascular; Homeostasis; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Urea | 2007 |
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Kidney; Kidney Diseases; Liver Diseases; Nitric Oxide; Nitric Oxide Synthase; Vasodilation | 2007 |
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Topics: Albuminuria; Arginine; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Humans; Kidney Diseases; Ossification, Heterotopic; Oxidative Stress; Risk Assessment; Uremia | 2008 |
15 trial(s) available for n,n-dimethylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
Topics: Administration, Oral; Adult; Alanine Transaminase; Arginine; Aspartate Aminotransferases; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Febuxostat; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Pancytopenia; Placebos; Prospective Studies; Renal Dialysis; Risk Factors; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2017 |
Lifestyle modification decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men.
Topics: Adult; Animals; Ankle Brachial Index; Arginine; Biomarkers; Caloric Restriction; Cardiovascular Diseases; Down-Regulation; Exercise; Humans; Male; Middle Aged; Obesity; Overweight; Pulse Wave Analysis; Risk Reduction Behavior; Time Factors; Treatment Outcome; Vascular Stiffness | 2013 |
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin.
Topics: Adolescent; Anticholesteremic Agents; Arginine; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Heptanoic Acids; Homoarginine; Humans; Lipids; Male; Pilot Projects; Pyrroles; Risk Factors; Treatment Outcome | 2015 |
Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
Topics: Aged; Animals; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Activation; Female; Humans; Male; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Signal Transduction; Simvastatin | 2016 |
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
Topics: Arginine; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Morbidity; Prospective Studies; Renal Dialysis | 2017 |
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
Topics: Adult; Antioxidants; Arginine; Ascorbic Acid; beta Carotene; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Double-Blind Method; Homocysteine; Humans; Male; Middle Aged; Protective Agents; Triglycerides; Vitamin B Complex; Vitamin E | 2010 |
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.
Topics: Administration, Oral; Aged; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B 12; Vitamin B Complex | 2010 |
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Linear Models; Male; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Renal Insufficiency; Risk Factors | 2011 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Diet; Endothelium, Vascular; Exercise; Exercise Therapy; Female; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Overweight; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk; Vascular Cell Adhesion Molecule-1 | 2012 |
Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease.
Topics: Arginine; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Renal Dialysis; Risk Factors; Sodium Chloride | 2002 |
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women.
Topics: Analysis of Variance; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Middle Aged; Nitric Oxide Synthase; Postmenopause; Protein Isoforms; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity | 2003 |
Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Humans; Isomerism; Middle Aged; Progesterone Congeners; Promegestone; Risk Factors; Spectrometry, Fluorescence | 2003 |
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Folic Acid; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Pyridoxine; Risk Factors; Time Factors; Treatment Failure; Vitamin B Complex | 2006 |
Effects of combined supplementation with B vitamins and antioxidants on plasma levels of asymmetric dimethylarginine (ADMA) in subjects with elevated risk for cardiovascular disease.
Topics: Adult; Aged; Antioxidants; Arginine; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Lipids; Male; Middle Aged; Risk Factors; Vitamin B Complex | 2007 |
176 other study(ies) available for n,n-dimethylarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Female; Humans; Male; Non-alcoholic Fatty Liver Disease; Tandem Mass Spectrometry | 2022 |
Prevalence of cardiovascular diseases in kidney transplant recipients and its relationship with asymmetric dimethylarginine, fibroblast growth factor-23 and multiple inflammatory markers.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fibroblast Growth Factor-23; Humans; Interleukin-6; Kidney Transplantation; Prevalence; Renal Insufficiency, Chronic; Water Intoxication | 2022 |
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Diabetic Nephropathies; Heart Failure; Humans; Renal Insufficiency, Chronic | 2023 |
Successful endodontic treatment reduces serum levels of cardiovascular disease risk biomarkers-high-sensitivity C-reactive protein, asymmetric dimethylarginine, and matrix metalloprotease-2.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; COVID-19; COVID-19 Vaccines; Glycated Hemoglobin; Humans; Matrix Metalloproteinase 2; Metabolic Syndrome | 2023 |
Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chemokines; Citrulline; Cytokines; Female; Growth Hormone; Humans; Lower Extremity; Male; Metabolomics; Middle Aged; Nitric Oxide; Wounds and Injuries | 2019 |
Blueberry anthocyanin‑enriched extract ameliorates transverse aortic constriction‑induced myocardial dysfunction via the DDAH1/ADMA/NO signaling pathway in mice.
Topics: Amidohydrolases; Animals; Anthocyanins; Aortic Valve Stenosis; Apoptosis; Arginine; Blueberry Plants; Cardiovascular Diseases; Disease Models, Animal; Gene Expression Regulation; Humans; Mice; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Plant Extracts; Signal Transduction | 2020 |
Cardiovascular risk factors and the concentration of asymmetric dimethylarginine.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Middle Aged; Risk Factors | 2020 |
Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
Topics: Adolescent; Adult; Angiopoietin-Like Protein 2; Angiopoietin-like Proteins; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Assessment; Young Adult | 2020 |
Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
Topics: Adult; Arginine; Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Fatty Acid-Binding Proteins; Female; Genetic Predisposition to Disease; Heart Disease Risk Factors; Humans; Male; Mexico; MicroRNAs; Polymorphism, Genetic; Sex Factors | 2020 |
Asymmetric dimethylarginine compartmental behavior during high-flux hemodialysis.
Topics: Adult; Arginine; Cardiovascular Diseases; Creatinine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Tandem Mass Spectrometry; Urea | 2020 |
Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease.
Topics: Adult; Arginine; Cardiovascular Diseases; End Stage Liver Disease; Heart Disease Risk Factors; Humans; Nitric Oxide; Risk Factors; Severity of Illness Index | 2020 |
Whole-body arginine dimethylation is associated with all-cause mortality in adult renal transplant recipients.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Female; Heart Disease Risk Factors; Humans; Kidney Transplantation; Male; Methylation; Middle Aged; Protein Processing, Post-Translational; Tissue Donors; Transplant Recipients | 2021 |
Profile of new vascular damage biomarkers in middle-aged men with arterial hypertension.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Follow-Up Studies; Humans; Hypertension; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Prognosis | 2021 |
Myeloperoxidase, asymmetric dimethyl-arginine and the renin-angiotensin-aldosterone-system in cardiovascular risk patients: Cross-sectional findings from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Topics: Aged; Aldosterone; Arginine; Austria; Biomarkers; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Cross-Sectional Studies; Female; Follow-Up Studies; Germany; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Male; Middle Aged; Mortality; Peroxidase; Predictive Value of Tests; Prevalence; Prospective Studies; Renin-Angiotensin System; Risk Factors | 2017 |
Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Chromatography, Liquid; Citrulline; Cohort Studies; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; omega-N-Methylarginine; Ornithine; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Tandem Mass Spectrometry | 2017 |
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; HIV Infections; Humans; Inflammation; Male; Methylamines; Middle Aged; Risk Factors; Tandem Mass Spectrometry | 2017 |
Asymmetric dimethylarginine and arginine metabolites in women with and without a history of gestational diabetes.
Topics: Adult; Arginine; Cardiovascular Diseases; Diabetes, Gestational; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Postpartum Period; Pregnancy; Prognosis | 2017 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar | 2017 |
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.
Topics: Aged; Aged, 80 and over; Amidohydrolases; Arginine; Australia; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Humans; Male; Mass Spectrometry; Middle Aged; Proton Pump Inhibitors; Risk Assessment | 2017 |
Association between vitamin D status and asymmetric dimethylarginine (ADMA) concentration in the Korean elderly population.
Topics: Aged; Aged, 80 and over; Arginine; Asian People; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Middle Aged; Vitamin D; Vitamin D Deficiency | 2017 |
Influence on serum asymmetric dimethylarginine (ADMA) concentrations of human paraoxonase 1 polymorphism (Q192R) and exposure to polycyclic aromatic hydrocarbons (PAHs) in Mexican women, a gene-environment interaction.
Topics: Adult; Alleles; Arginine; Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Creatinine; Environmental Exposure; Environmental Pollutants; Female; Gene Frequency; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Mexico; Polycyclic Aromatic Hydrocarbons; Polymorphism, Genetic; Pyrenes; Risk Factors | 2017 |
Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study.
Topics: Adult; Arginine; Black People; Cardiovascular Diseases; Carotid Intima-Media Thickness; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; South America; White People | 2017 |
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Disease Progression; Female; Germany; Humans; Incidence; Male; Middle Aged; omega-N-Methylarginine; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2018 |
Serum Concentrations of New Predictive Cardiovascular Disease Biomarkers in Mexican Women Exposed to Lead.
Topics: Adiponectin; Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Chemokines; Cross-Sectional Studies; Environmental Exposure; Fatty Acid-Binding Proteins; Female; Humans; Intercellular Signaling Peptides and Proteins; Lead; Male; Mexico; Middle Aged | 2018 |
Increased Endothelial Dysfunction and Insulin Resistance in Patients with Klinefelter Syndrome.
Topics: Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Endothelium, Vascular; Humans; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Klinefelter Syndrome; Male; Multivariate Analysis; Prevalence; Risk Factors; Testosterone; Turkey; Young Adult | 2018 |
Association of endothelial dysfunction with cardiovascular risk factors and new-onset diabetes mellitus in patients with hypertension.
Topics: Aged; Arginine; Brazil; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Predictive Value of Tests; Prospective Studies; Risk Factors; Triglycerides | 2018 |
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
Topics: Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium; Feces; Female; Gastrointestinal Microbiome; HIV Infections; Humans; Inflammation; Kynurenine; Male; Metabolism; Middle Aged; Neopterin; Risk Factors; RNA, Ribosomal, 16S; Tryptophan | 2018 |
Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Topics: Aged; Arginase; Arginine; Arthritis, Rheumatoid; Biomarkers; Cardiovascular Diseases; Comorbidity; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; United States | 2018 |
Cyclooxygenase-2, Asymmetric Dimethylarginine, and the Cardiovascular Hazard From Nonsteroidal Anti-Inflammatory Drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Celecoxib; Creatinine; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoarthritis; Placebo Effect | 2018 |
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Homoarginine; Humans; Incidence; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
ADMA and NT pro-BNP are associated with overall mortality in elderly.
Topics: Age Distribution; Aged; Aged, 80 and over; Arginine; Austria; Biomarkers; Body Mass Index; Cardiovascular Diseases; Female; Health Services for the Aged; Hospitalization; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Factors; Sex Distribution; Survival Analysis | 2019 |
Impact of arsenic exposure on clinical biomarkers indicative of cardiovascular disease risk in Mexican women.
Topics: Adult; Aged; Arginine; Arsenic; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Drinking Water; Environmental Exposure; Fatty Acid-Binding Proteins; Female; Humans; Male; Mexico; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Factors; Surveys and Questionnaires; Water Pollutants, Chemical | 2019 |
Protein-energy wasting and asymmetric dimethylarginine in peritoneal dialysis patients.
Topics: Adiponectin; Adult; Aged; Arginine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Energy Metabolism; Humans; Interleukin-6; Kidney Failure, Chronic; Leptin; Lipoproteins, LDL; Middle Aged; Peritoneal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensins; Animals; Arginine; Cardiovascular Diseases; Deoxyguanosine; Disease Models, Animal; Humans; Hypertension; Hypoxia; Kidney; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidative Stress; Sympathectomy; Sympathetic Nervous System | 2018 |
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine.
Topics: Arginine; Cardiovascular Diseases; HEK293 Cells; Homoarginine; Humans; Inhibitory Concentration 50; Kidney; Kinetics; Organic Anion Transporters; Toxins, Biological | 2019 |
Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Creatinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Kidney Transplantation; Male; Middle Aged; Netherlands; Tandem Mass Spectrometry; Transplant Recipients | 2019 |
Establishment of reference values for the lysine acetylation marker N
Topics: Adolescent; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Carnitine; Chromatography, Liquid; Citrulline; Creatinine; Female; Homoarginine; Humans; Lysine; Male; Middle Aged; Ornithine; Reference Values; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Young Adult | 2019 |
Heat-assisted extraction for the determination of methylarginines in serum by CE.
Topics: Arginine; Cardiovascular Diseases; Electrophoresis, Capillary; Hot Temperature; Humans; omega-N-Methylarginine; Solid Phase Extraction | 2013 |
Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism.
Topics: Adult; Antioxidants; Arginine; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hypothyroidism; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide; Risk Factors | 2013 |
Editorial (hot topic: cardiovascular disease biomarkers: from tradition to modernity).
Topics: Adiponectin; Arginine; Biomarkers; Cardiovascular Diseases; Cystatin C; Endothelins; Glycopeptides; Humans; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Peroxidase; Predictive Value of Tests; Troponin | 2013 |
Asymmetric dimethylarginine predicts survival in the elderly.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Chromatography, Liquid; Female; Follow-Up Studies; Humans; Italy; Male; Population Surveillance; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Tandem Mass Spectrometry; Time Factors | 2013 |
Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Inflammation; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; ROC Curve; Serum Albumin; Serum Amyloid A Protein | 2013 |
Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Endothelium; Female; Gene Expression; Humans; Kidney; Male; Middle Aged; Prognosis; Renal Insufficiency, Chronic; RNA, Messenger; Serum Amyloid P-Component; Subcutaneous Fat, Abdominal; Uremia; Vascular Resistance | 2013 |
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Proton Pump Inhibitors; Risk Factors; Vasodilation | 2013 |
Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Topics: Aged; Aged, 80 and over; Arginine; Atrial Fibrillation; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Referral and Consultation; Risk Assessment; Risk Factors; Stroke; Survival Rate; Time Factors | 2013 |
Effects of acute and chronic stress on the L-arginine nitric oxide pathway in black and white South Africans: the sympathetic activity and ambulatory blood pressure in Africans study.
Topics: Acute Disease; Adult; Arginine; Black People; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Chronic Disease; Cold Temperature; Cross-Sectional Studies; Disease Susceptibility; Female; Hemodynamics; Humans; Male; Middle Aged; Motor Activity; Nitric Oxide; Pressure; Rest; South Africa; Stress, Psychological; Stroop Test; White People | 2013 |
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Factors; Texas | 2013 |
The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
Topics: Adenosine Deaminase; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cross-Sectional Studies; Female; HIV Infections; HIV Seropositivity; Humans; Immunoglobulin G; Interleukin-6; Male; Viral Load | 2014 |
Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Environment; Female; Genotype; Humans; Intermittent Claudication; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors | 2014 |
Lipoprotein apheresis reduces biomarkers of plaque destabilization and cardiovascular risk.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Component Removal; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Lipoproteins; Male; Matrix Metalloproteinase 9; Middle Aged; Plaque, Atherosclerotic; Pregnancy-Associated Plasma Protein-A; Vascular Cell Adhesion Molecule-1 | 2014 |
Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.
Topics: Aged; Arginine; Arthritis, Rheumatoid; Cardiovascular Diseases; Endocardium; Female; Humans; Male; Middle Aged; Risk Assessment | 2014 |
Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics.
Topics: Adolescent; Arginine; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Egypt; Electrocardiography; Female; Humans; Lipids; Male; Nitric Oxide; Ultrasonography | 2014 |
Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Topics: Adult; Analysis of Variance; Antiviral Agents; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Depression; Depressive Disorder; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Nitric Oxide Synthase; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Ribavirin; Risk Factors; Time Factors | 2014 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endothelium, Vascular; Fasting; Humans; Islam; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Peripheral Arterial Disease; Vascular Endothelial Growth Factor A | 2014 |
Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Female; Humans; Incidence; Male; Middle Aged; Young Adult | 2014 |
GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples.
Topics: Arginine; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Homoarginine; Humans; Male; Risk Factors; Sputum | 2014 |
Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Topics: Adult; Aged; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homoarginine; Humans; Male; Middle Aged; Reference Values; Renal Insufficiency, Chronic; Risk Factors; Tandem Mass Spectrometry | 2014 |
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
Topics: Aged; Arginine; Aspirin; Biomarkers; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Wnt Signaling Pathway | 2014 |
Aging of the nitric oxide system: are we as old as our NO?
Topics: Aged; Aging; Arginine; Blood Platelets; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nitric Oxide; Platelet Aggregation; Prospective Studies | 2014 |
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study.
Topics: Aged; Arginine; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Regression Analysis; Risk Factors; Severity of Illness Index | 2015 |
Cardiovascular-renal changes after kidney donation: one-year follow-up study.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Interleukin-6; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Nephrectomy; Prospective Studies; Risk Factors; Time Factors; Tissue Donors; Treatment Outcome; Uric Acid; Vascular Cell Adhesion Molecule-1; Vasodilation; Young Adult | 2015 |
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART.
Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Arginine; Bacterial Translocation; Biomarkers; Cardiovascular Diseases; Female; Fibrin Fibrinogen Degradation Products; HIV Infections; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Middle Aged; Monocytes | 2014 |
Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs.
Topics: Adult; Animals; Anti-Inflammatory Agents; Arginine; Biomarkers; Cardiovascular Diseases; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Culture Techniques; Young Adult | 2015 |
Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.
Topics: Adult; Arginine; Arthritis, Psoriatic; Asymptomatic Diseases; Atherosclerosis; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Severity of Illness Index; Vasodilation | 2015 |
Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Arginine; Blood Platelets; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Integrin beta3; Interleukin-6; Male; Middle Aged; Monocytes; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Risk Factors; Smoking; Stents | 2015 |
The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Glomerular Filtration Rate; Humans; Longitudinal Studies; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency, Chronic; Retrospective Studies; Serum Albumin; Triglycerides | 2015 |
Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children.
Topics: Adolescent; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Cardiomyopathies; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hyperglycemia; Japan; Male; Pediatric Obesity; Risk | 2015 |
The relationship between serum asymmetric dimethylarginine levels and subjective sleep quality in normotensive patients with type 2 diabetes mellitus.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Sleep; Sleep Wake Disorders; Surveys and Questionnaires | 2015 |
Heat Shock Proteins, L-Arginine, and Asymmetric Dimethylarginine Levels in Patients With Obstructive Sleep Apnea Syndrome.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Disease Susceptibility; Endothelium, Vascular; Female; Heat-Shock Proteins; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Obesity; Oxidative Stress; Polysomnography; Risk Factors; Sleep Apnea, Obstructive; Smoking; Turkey | 2015 |
ADMA and arginine derivatives in relation to non-invasive vascular function in the general population.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Germany; Humans; Male; Middle Aged; Nitric Oxide Synthase; Population Surveillance; Prevalence; Retrospective Studies; Vasodilation | 2016 |
Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.
Topics: Adolescent; Alleles; Arginine; Atherosclerosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Lipids; Male; Pediatric Obesity; Polymorphism, Genetic; Receptor for Advanced Glycation End Products; Regression Analysis; Risk Factors | 2016 |
Relationship between FEV
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-6; Italy; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Risk Factors; Statistics as Topic; Vascular Stiffness | 2017 |
Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Topics: Academic Medical Centers; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Uric Acid | 2016 |
Osteoprotegerin, RANKL, ADMA, and Fetuin-A serum levels in children with type I diabetes mellitus.
Topics: Adolescent; alpha-2-HS-Glycoprotein; Arginine; Biomarkers; Cardiovascular Diseases; Child; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Cardiomyopathies; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Greece; Humans; Male; Osteoprotegerin; RANK Ligand; Reproducibility of Results | 2017 |
Elevated plasma ADMA contributes to development of endothelial dysfunction in children with acute lymphoblastic leukemia.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Endothelial Cells; Endothelium-Dependent Relaxing Factors; Enzyme Inhibitors; Female; Humans; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2016 |
Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxidative Stress; Prognosis; Prospective Studies; Risk Factors; Young Adult | 2017 |
[Effect of asymmetrical dimethylarginine for predicting pro-thrombotic risk in atrial fibrillation].
Topics: Arginine; Atrial Fibrillation; Cardiovascular Diseases; Heart Atria; Humans; Stereoisomerism; Thrombosis | 2016 |
Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2.
Topics: Aminoisobutyric Acids; Animals; Arginine; Cardiovascular Diseases; Cell Line; Diabetes Mellitus, Type 2; Gene Expression Regulation; Hepatocyte Nuclear Factor 4; Humans; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk; RNA, Small Interfering; Transaminases | 2016 |
Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Cardiovascular Diseases; Carotid Stenosis; Cohort Studies; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Multivariate Analysis; Proportional Hazards Models; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2018 |
Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Renal Dialysis; Risk Factors | 2008 |
Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the cardiovascular risk in young Finns study.
Topics: Adult; Arginine; Blood Pressure; Cardiovascular Diseases; Female; Finland; Humans; Kidney; Lipids; Male; Nitric Oxide; Risk Factors; Vascular Resistance; Vasoconstriction; Young Adult | 2008 |
[Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Stenosis; Chromatography; Enzyme Inhibitors; Female; Homocysteine; Humans; Insulin Resistance; Linear Models; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography, Doppler, Color | 2008 |
Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives.
Topics: Adult; Arginine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Hypertension; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Risk Factors; Severity of Illness Index; Sleep Apnea, Obstructive; Tumor Necrosis Factor-alpha | 2009 |
Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea.
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Case-Control Studies; CD40 Ligand; Endothelin-1; Humans; Male; Middle Aged; Risk Factors; Sleep Apnea, Obstructive | 2009 |
Smoker's paradox in heart failure: might asymmetric dimethylarginine be the possible explanation?
Topics: Arginine; Cardiovascular Diseases; Heart Failure; Hospital Mortality; Humans; Smoking | 2008 |
Plasma levels of asymmetric dimethylarginine in premature neonates: its possible involvement in developmental programming of chronic diseases.
Topics: Arginine; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Metabolic Syndrome | 2009 |
The beneficial effects of angiotensin-converting enzyme inhibitors on serum asymmetric dimethylarginine levels in the patients with cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine; Biomarkers; Cardiovascular Diseases; Humans | 2010 |
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mass Spectrometry; Middle Aged; Nitric Oxide; Proportional Hazards Models; Prospective Studies; Risk | 2009 |
Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Arteries; Humans; Kidney Diseases; Kidney Failure, Chronic; Risk Factors; Uremia | 2009 |
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
Topics: Aged; Arginine; Cardiovascular Diseases; Cause of Death; Diabetes Mellitus; Follow-Up Studies; Humans; Incidence; Middle Aged; Mortality; Predictive Value of Tests; Prognosis; Proportional Hazards Models | 2009 |
HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children.
Topics: Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Child; Cholesterol, HDL; Cross-Sectional Studies; Disease Progression; Female; Humans; Male; New South Wales; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2009 |
Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.
Topics: Age Factors; Aged; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Cohort Studies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Reference Standards; Sensitivity and Specificity; Sex Factors; Tandem Mass Spectrometry | 2009 |
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors | 2009 |
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Risk Factors; Th1 Cells; Young Adult | 2009 |
Determinants of occurrence of aortic sclerosis in an aging population.
Topics: Age Factors; Aged; Aorta; Aortic Valve; Aortic Valve Stenosis; Arginine; Biomarkers; Blood Platelets; Body Mass Index; Calcinosis; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Echocardiography, Doppler; Elasticity; Endothelium, Vascular; Female; Heart Valve Diseases; Humans; Linear Models; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Platelet Aggregation; Prospective Studies; Pulsatile Flow; Risk Assessment; Risk Factors; Sclerosis | 2009 |
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients.
Topics: Adult; Arginine; Cardiovascular Diseases; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome | 2010 |
Asymmetric dimethylarginine: understanding the physiology, genetics, and clinical relevance of this novel biomarker. Proceedings of the 4th International Symposium on ADMA.
Topics: Arginine; Austria; Biomarkers; Cardiovascular Diseases; Humans; Internationality; Nitric Oxide | 2009 |
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities.
Topics: Aged; Arginine; Asian People; Black People; Cardiovascular Diseases; Cystatin C; Enzyme-Linked Immunosorbent Assay; Female; Glomerular Filtration Rate; Hispanic or Latino; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; White People | 2010 |
Circulating angiopoietin-2 levels increase with progress of chronic kidney disease.
Topics: Adult; Aged; Angiopoietin-2; Arginine; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Chronic Disease; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Nephrectomy; Risk Factors; Tissue Donors | 2010 |
Dimethylarginine dimethylaminohydrolase overexpression ameliorates atherosclerosis in apolipoprotein E-deficient mice by lowering asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Aorta; Apolipoproteins E; Arginine; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Humans; Male; Mice; Mice, Transgenic; Models, Genetic; Nitric Oxide; Risk | 2010 |
Association between exaggerated blood pressure response to exercise and serum asymmetric dimethylarginine levels.
Topics: Adult; Arginine; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Exercise; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Predictive Value of Tests | 2010 |
[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Blood Proteins; Cardiovascular Diseases; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Female; Humans; Hyperhomocysteinemia; Hyperlipidemias; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prevalence; Risk Factors; Smoking; Stroke Volume; Ultrasonography; Uremia | 2010 |
HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application.
Topics: Adolescent; Adult; Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Creatine; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency, Chronic; Young Adult | 2010 |
Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Risk Factors; Spondylitis, Ankylosing | 2011 |
Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Topics: Adiponectin; Adult; Aged; Aldehydes; Arginine; Biomarkers; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Endothelium; Female; Humans; Inflammation; Interleukin-6; Leptin; Lipoproteins, LDL; Male; Malnutrition; Malondialdehyde; Middle Aged; Nutritional Status; Oxidative Stress; Peritoneal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2010 |
Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Endothelium, Vascular; Female; Finland; Humans; Male; Middle Aged; Multivariate Analysis; Risk Factors | 2010 |
Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Female; Hormones; Humans; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2011 |
Serum asymmetric dimethylarginine levels in normotensive obese individuals.
Topics: Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Male; Middle Aged; Obesity; Risk Factors | 2010 |
Asymmetric dimethylarginine as a risk factor for cardiovascular disease in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Arginine; Asian People; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Regression Analysis; Risk Factors | 2011 |
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Inhibitors; Epidemiologic Methods; Female; Germany; Humans; Male; Nitric Oxide Synthase; Peripheral Arterial Disease; Prognosis | 2011 |
Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
Topics: Adolescent; Albuminuria; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Risk Factors | 2011 |
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Topics: Aged; Amidohydrolases; Analysis of Variance; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cohort Studies; Coronary Angiography; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Insulin; Insulin Resistance; Kaplan-Meier Estimate; Linear Models; Linkage Disequilibrium; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Genetic; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Taiwan | 2011 |
NO problem: arterial and venous endothelial function and erectile dysfunction.
Topics: Arginine; Arteries; Biomarkers; Blood Flow Velocity; Cardiovascular Diseases; Endothelium, Vascular; Humans; Impotence, Vasculogenic; Male; Nitric Oxide; Penile Erection; Penis; Predictive Value of Tests; Regional Blood Flow; Risk Assessment; Risk Factors; Severity of Illness Index; Ultrasonography, Doppler, Color; Up-Regulation; Veins | 2011 |
Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction.
Topics: Adult; Aged; Analysis of Variance; Arginine; Arteries; Biomarkers; Blood Flow Velocity; Cardiovascular Diseases; Case-Control Studies; Greece; Humans; Impotence, Vasculogenic; Male; Middle Aged; Penile Erection; Penis; Predictive Value of Tests; Regional Blood Flow; Regression Analysis; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Ultrasonography, Doppler, Color; Up-Regulation; Veins | 2011 |
Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease.
Topics: Adult; Arginine; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Graves Disease; Heart Rate; Hospitals, University; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Natriuretic Peptide, Brain; Peptide Fragments; Risk Factors; Thyroid Hormones; Thyroxine; Triiodothyronine | 2011 |
Exercise-induced alterations of retinal vessel diameters and cardiovascular risk reduction in obesity.
Topics: Adult; Arginine; Athletes; Cardiovascular Diseases; Enzyme-Linked Immunosorbent Assay; Exercise; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Nitric Oxide; Obesity; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; Surveys and Questionnaires | 2011 |
Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors; Young Adult | 2011 |
Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Endothelial Cells; Enzyme Inhibitors; Female; Genotype; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenotype; Risk Factors; RNA Interference; Substrate Specificity; Time Factors; Transfection | 2011 |
Vascular function in the diagnostic categories of polycystic ovary syndrome.
Topics: Adult; Arginine; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Overweight; Phenotype; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Resistance | 2011 |
Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients.
Topics: Adult; Aged; Analysis of Variance; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cohort Studies; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Italy; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proportional Hazards Models; Renal Dialysis; Risk Assessment; Risk Factors; Time Factors | 2011 |
DDAH says NO to ADMA.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Risk Factors; Substrate Specificity | 2011 |
Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors.
Topics: Aged; Aged, 80 and over; Aging; Apolipoproteins A; Arginine; Cardiovascular Diseases; Catalase; Enzyme-Linked Immunosorbent Assay; Female; Fetuins; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Male; Oxidation-Reduction; Oxidative Stress; Risk Factors; Statistics as Topic; Superoxide Dismutase | 2012 |
Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Death; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Referral and Consultation; Risk Factors | 2011 |
Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea.
Topics: Adult; Arginine; Blood Coagulation; Body Mass Index; Cardiovascular Diseases; CD40 Ligand; Circadian Rhythm; Endothelium, Vascular; Erythrocyte Count; Factor VII; Humans; Leukocyte Count; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Count; Sleep Apnea Syndromes; von Willebrand Factor; Waist Circumference | 2012 |
Asymmetric dimethylarginine (ADMA): is really a biomarker for cardiovascular prognosis?
Topics: Arginine; Cardiovascular Diseases; Coronary Angiography; Female; Humans; Male; Referral and Consultation | 2011 |
Endothelial dysfunction and high cardiovascular risk profile in severe alcoholics improve only partially following a medium-term alcohol withdrawal.
Topics: Adult; Age of Onset; Aged; Alcoholism; Arginine; Biomarkers; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Confidence Intervals; Endothelium, Vascular; Female; Heart Rate; Humans; Insulin Resistance; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Oxidative Stress; Risk Assessment; Smoking; Vasodilation | 2012 |
Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; HL-60 Cells; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Animal; Neutrophils; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxidase; Signal Transduction; Superoxides | 2011 |
Ethnicity-specific differences in L-arginine status in South African men.
Topics: Adult; Aged; Arginine; Black People; Cardiovascular Diseases; Cross-Sectional Studies; Humans; Hypertension; Linear Models; Male; Middle Aged; Multivariate Analysis; Prevalence; Risk Factors; South Africa; White People | 2012 |
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence.
Topics: Animals; Apoptosis; Arginine; Autophagy; Azoles; Cardiovascular Diseases; Cathepsins; Cell Membrane Permeability; Cells, Cultured; Cellular Senescence; Collagen Type I; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Hydrogen Peroxide; Isoindoles; Lysosomes; Mice; Mice, Knockout; Mice, Transgenic; Organoselenium Compounds; Recombinant Proteins; Risk Factors; Sirtuin 1; Stem Cells; Stress, Physiological | 2012 |
High tea and vegetable consumption is associated with low ADMA generation in older healthy subjects.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Coffee; Enzyme Inhibitors; Feeding Behavior; Female; Fruit; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Nitric Oxide Synthase; Reference Values; Risk Factors; Tea; Vegetables | 2012 |
Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Carotid Intima-Media Thickness; Demography; Female; Humans; Indonesia; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Renal Dialysis; Risk Factors | 2012 |
The association between serum asymmetric dimethyl arginine levels and a history of gestational diabetes among healthy women.
Topics: Adult; Arginine; Asymptomatic Diseases; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Diabetes Complications; Diabetes, Gestational; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Pregnancy; Risk Factors | 2012 |
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1).
Topics: Arginine; Biological Transport; Biomarkers; Cardiovascular Diseases; Cationic Amino Acid Transporter 1; Gene Expression; HEK293 Cells; Humans; Kinesics; Metformin; Risk | 2012 |
Elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Survivors | 2012 |
Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Cell Adhesion Molecule-1; Waist Circumference; Weight Loss | 2012 |
Exploring disease activity and cardiovascular events by raised serum asymmetric dimethyl arginine among systemic lupus erythematosus patients.
Topics: Adult; Arginine; Cardiovascular Diseases; Cholesterol; Complement C3; Cross-Sectional Studies; Egypt; Female; Humans; Logistic Models; Lupus Erythematosus, Systemic; Male; Surveys and Questionnaires | 2011 |
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.
Topics: Adult; Aged; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Cross-Sectional Studies; Endothelial Cells; Fasting; Female; Femoral Artery; Glucose Tolerance Test; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Prediabetic State; Predictive Value of Tests; Pulse Wave Analysis; Risk Assessment; Risk Factors; Stem Cells; Vascular Stiffness | 2012 |
The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.
Topics: Adolescent; Aged; Arginine; Aspirin; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Echocardiography; Heart; Humans; Hypertension; Middle Aged; Peritoneal Dialysis; Risk Factors | 2013 |
Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aging; Amidohydrolases; Arginine; Australia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Community Medicine; Cysteine; Dipeptides; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Taurine | 2013 |
Endothelial damage, asymmetric dimethylarginine and cardiovascular risk in end-stage renal disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Kidney Failure, Chronic; Models, Cardiovascular; Risk Factors | 2002 |
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?
Topics: Arginine; Cardiovascular Diseases; Homocysteine; Humans; Predictive Value of Tests; Risk Factors | 2002 |
High-performance liquid chromatographic assay of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine in human plasma by derivatization with naphthalene-2,3-dicarboxaldehyde.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Naphthalenes; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Stereoisomerism | 2003 |
When the endothelium cannot say 'NO' anymore. ADMA, an endogenous inhibitor of NO synthase, promotes cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Humans; Nitric Oxide; Nitric Oxide Synthase | 2003 |
Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease.
Topics: Aged; Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mitochondrial Proton-Translocating ATPases; Oxidative Phosphorylation Coupling Factors; Radioimmunoassay; Risk Factors | 2003 |
Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase.
Topics: Arginine; Cardiovascular Diseases; Endothelium, Vascular; Enzyme Inhibitors; Homeostasis; Humans; Hyperhomocysteinemia; Hyperlipidemias; Nitric Oxide Synthase; Vasodilation | 2003 |
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Cells, Cultured; Coronary Angiography; Coronary Artery Disease; Cyclic GMP; Cytomegalovirus Infections; Endothelium, Vascular; Female; Heart Transplantation; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitrites; Oxidative Stress; Risk Factors; Signal Transduction | 2004 |
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
Topics: Adult; Aged; Arginine; Arteriosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis | 2005 |
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arginine; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; E-Selectin; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Nitric Oxide Synthase; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones | 2006 |
The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Enzyme Inhibitors; Female; Homocysteine; Hormone Replacement Therapy; Humans; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Nitric Oxide; Risk Factors; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Topics: Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Creatinine; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors | 2005 |
Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Severity of Illness Index | 2005 |
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
Topics: Adult; Aged; Amino Acid Substitution; Analysis of Variance; Arginine; Aspartic Acid; Cardiovascular Diseases; Female; Gene Frequency; Genotype; Glutamic Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Polymorphism, Genetic; Regression Analysis; Survival Rate | 2005 |
Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects.
Topics: Adult; Aged; Aging; Arginine; Biomarkers; Cardiovascular Diseases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Reference Values; Sensitivity and Specificity; Sex Characteristics | 2005 |
Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA.
Topics: Arginine; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein Receptors, Type I; Bone Morphogenetic Proteins; Cardiovascular Diseases; Cell Culture Techniques; Endothelial Cells; Gene Expression Profiling; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Oligonucleotide Array Sequence Analysis; Protein-Arginine N-Methyltransferases; Smad5 Protein; Transforming Growth Factor beta | 2005 |
ADMA, endothelial progenitor cells, and cardiovascular risk.
Topics: Arginine; Cardiovascular Diseases; Endothelial Cells; Humans; Risk Factors; Stem Cells | 2005 |
The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Topics: Adult; Arginine; Brachial Artery; Cardiovascular Diseases; Chronic Disease; Copper; Endothelium, Vascular; Erythrocytes; Female; Glomerular Filtration Rate; Glutathione Peroxidase; Humans; Kidney Diseases; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Selenium; Severity of Illness Index; Superoxide Dismutase; Vasodilation; Zinc | 2006 |
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cyclic GMP; Exercise; Female; Humans; Male; Middle Aged; Peroxidase; Risk Factors | 2005 |
Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide.
Topics: Aged; Arginine; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Folic Acid; Genetic Variation; Genotype; Homocysteine; Humans; Linkage Disequilibrium; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Postmenopause; Risk Factors; Vitamin B 12 | 2006 |
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
Topics: Aged; Arginine; Arteries; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Osmolar Concentration; Peripheral Vascular Diseases; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Severity of Illness Index | 2006 |
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Comorbidity; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Proportional Hazards Models; Regression Analysis; Renal Dialysis; Risk Factors | 2006 |
Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).
Topics: Analysis of Variance; Arginine; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Mortality; Predictive Value of Tests; Regression Analysis; Risk Factors | 2007 |
Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Coronary Artery Disease; Humans; Mortality; Predictive Value of Tests; Risk Factors | 2007 |
ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.
Topics: Adult; Aged; Analysis of Variance; Arginine; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Insulin; Male; Middle Aged; Risk Factors; Vasodilation | 2007 |
A new perspective for the treatment of renal diseases?
Topics: Amidohydrolases; Arginine; Cardiovascular Diseases; Chronic Disease; Humans; Kidney Diseases; Nitric Oxide Synthase; Risk Factors | 2007 |
Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
Topics: Aged; Arginine; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk Assessment | 2007 |
Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nitric Oxide Synthase; Perioperative Care; Postoperative Complications; Prospective Studies; Risk Assessment; Surgical Procedures, Operative | 2007 |
Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
Topics: Adult; Arginine; Biomarkers; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Finland; Follow-Up Studies; Hemorheology; Humans; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Risk; Sampling Studies; Vasodilation | 2007 |
Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease.
Topics: Adult; Arginine; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Female; Humans; Insulin Resistance; Middle Aged; Obesity; Overweight; Premenopause; Regression Analysis; Risk Factors | 2007 |
Oxidative stress in cardiovascular disease: successful translation from bench to bedside?
Topics: Arginine; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Hemorheology; Humans; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Risk; Thrombosis; Vasodilation | 2007 |
Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Topics: Adult; Aged; Arginine; Blood Flow Velocity; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Circulation; Exercise Test; Female; Humans; Male; Middle Aged; Myocardium; Nitric Oxide; Sensitivity and Specificity; Thrombolytic Therapy | 2007 |
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
Topics: Acetylcholine; Amidohydrolases; Animals; Aorta; Arginine; Arterioles; Cardiovascular Diseases; Carotid Arteries; Cerebrovascular Circulation; Endothelium, Vascular; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Vasodilator Agents | 2008 |
Asymmetric dimethylarginine and impaired cardiovascular healing.
Topics: Apoptosis; Arginine; Cardiovascular Diseases; Humans; Kidney Diseases; Myocardial Ischemia; Nitric Oxide; Prognosis; Regeneration; Stem Cells; Treatment Outcome | 2009 |
Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diet; Homocysteine; Hyperhomocysteinemia; Male; Mesenteric Arteries; Methionine; Rats; Rats, Wistar; Vasodilation | 2008 |
The homocysteine paradox.
Topics: Animals; Arginine; Cardiovascular Diseases; Cystatin C; Cystatins; Disease Models, Animal; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Hypertension; Hypoglycemic Agents; Lipoproteins; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Vasodilator Agents | 2002 |
Insulin resistance, ADMA levels, and cardiovascular disease.
Topics: Arginine; Cardiovascular Diseases; Enzyme Inhibitors; Humans; Insulin Resistance; Metabolic Syndrome; Nitric Oxide Synthase; Risk Factors | 2002 |